Sanofi is here to support you and your patients.
Ask us your questions about our products, patient materials or organising a meeting.
Sparta Summary
In this clinical summary you discover the real-world evidence of Toujeo in people with T1 diabetes living in the UK. This was conducted in the SPARTA study - a descriptive, retrospective study.
Sparta Video
In the short video (2.35 min) you’ll learn about the results of the SPARTA study in T1 diabetes. This descriptive, retrospective study represents the real-world experience of using Toujeo® in 300 patients with T1DM in the UK.
Toujeo
Toujeo® is indicated as treatment of diabetes mellitus in adults, adolescents and children from the age of 6 years.
Patient Website
Find resources and support for your patients on Toujeo®. Help patients understand the basics of living and staying well with diabetes and how to have a positive start and experience with the medication prescribed to them.
MAT-XU-2205632 (v3.0)
Date of Preparation: September 2023
